Results 121 to 130 of about 108,939 (230)

Understanding the Burden of Orofacial Involvement and Patient Treatment Preferences in Systemic Sclerosis: Results From a Large International Survey

Arthritis Care &Research, EarlyView.
Objective Orofacial manifestations are significantly impactful in patients with systemic sclerosis (SSc) yet remain understudied, with no dedicated clinical guidelines to inform their management. Methods An international online survey comprised38 questions addressing orofacial manifestations of SSc, including patients’ confidence in their treating ...
Eleni Deligianni, Lee Shapiro, Deana Gibbs, Zsuzsanna H. McMahan, Michael Hughes   +4 more
wiley   +1 more source

Alcohol-Induced Early-Stage Liver Injury Contributes to Increases in Voluntary Alcohol Intake and Cognitive Deficits in Mice. [PDF]

Alcohol Clin Exp Res (Hoboken)
Skinner SG, Aleman EG, Rivera J, Kalapatapu N, Kantilal D, Davies DL, Asatryan L.   +6 more
europepmc   +1 more source

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

Arthritis Care &Research, EarlyView.
Catherine Deffendall, Jodi Backalar, Elizabeth Acevedo Zapata, Adriana Della Porta, Lorin Bibb, Tyler Reese, Charlotte M. Brown   +6 more
wiley   +1 more source

Association of Elevated Platelets and C‐Reactive Protein With Severe Disease and Poor Survival in Systemic Sclerosis

Arthritis Care &Research, EarlyView.
Objective Elevated C‐reactive protein (CRP) levels in systemic sclerosis (SSc) have been linked with severe disease and worse survival, but the role of platelet levels remains unclear. This study examined whether elevated platelet levels, CRP levels, or both are associated with disease severity, progression, and survival in SSc.
Brian S. Lee, Shufeng Li, Srijana Davuluri, Jennifer Lee, Lorinda Chung   +4 more
wiley   +1 more source

DMPK 3' untranslated repeat expansions in unexplained sudden cardiac death in the young. [PDF]

Eur Heart J
Ward Z, O'Neill J, Stiles R, Phua HH, Burcher S, Earle N, Martin A, Mok JX, Crawford J, Eaton J, Hogan S, Worgan L, Gray B, Burns C, Donoghue T, Stiles MK, Yeates L, Print CG, Hayes I, Skinner JR, Bagnall RD, Le Quesne Stabej P.   +21 more
europepmc   +1 more source

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)

Arthritis Care &Research, EarlyView.
Objective Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures.
Kevin Byram, Heřman Mann, Danielle Hammond, Onima Chowdhury, Sinisa Savic, Yohei Kirino, Carmelo Gurnari, Maël Heiblig, Thibault Comont, Arsène Mekinian, Mrinal M. Patnaik, Lachelle D. Weeks, Gary Ho, Adam Al‐Hakim, Scott Goldberg, Marcela A. Ferrada, Sophie Georgin‐Lavialle, Peter C. Grayson, Emma M. Groarke, Bhavisha Patel, Megan Sullivan, Sarah A. Buckley, Bryan G. Harder, Raman Garcha, David B. Beck, Matthew J. Koster   +25 more
wiley   +1 more source

Douglas Reid Skinner

Il Tolomeo, 2020
Fazzini, Marco
doaj   +1 more source

Dare Devil Alma and Skid Skinner

, 2004
Alma Morley (Dare Devil Alma) (married in 1941 to become Alma Skinner) and Skid Skinner (Hector Skinner), photographed standing next to an Indian motorcycle inside a Wall of Death, Norway ...
Skinner, Alma
core  

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

Arthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho, Shangyi Gao, Daniel Pereira, Richard J. Cook, Dafna D. Gladman   +4 more
wiley   +1 more source

Pharyngeal Electrical Stimulation versus None for Post-Stroke Dysphagia: Rationale, Design, and Protocol for the Parallel Group Superiority Pharyngeal Electrical Stimulation for Acute Stroke Dysphagia Trial (PhEAST) (ISRCTN98886991). [PDF]

Cerebrovasc Dis Extra
Benfield JK, Everton LF, Woodhouse LJ, Mhlanga II, Latulipe C, Skinner CJC, Buck A, Squires G, Roadevin C, Fiddy-Kent R, Munsif N, Wilkinson G, Cadman KM, Hamilton T, Smith P, Appleton JP, Dziewas R, Iversen HK, Krishnan K, Matz K, Mistry S, Smith CJ, Steiner T, Sprigg N, Montgomery AA, James M, England TJ, Hamdy S, Bath PM.   +28 more
europepmc   +1 more source